[ Price : $8.95]
FDA says a Tennessee federal judge entered a consent decree against two companies to prohibit them from distributing drugs, dietar...[ Price : $8.95]
FDA warns Stemell about multiple violations in its production of umbilical cord and umbilical cord blood products.[ Price : $8.95]
Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Millennium Pharmaceuticals ...[ Price : $8.95]
CDER deputy center director for clinical science Robert Temple discusses the move by industry and the agency to the third age of d...[ Price : $8.95]
Federal Register notice: FDA extends the comment period for an 8/2 notice on a draft guidance on testing and labeling medical devi...[ Price : $8.95]
FDA warns Chinas Yino, Inc., about significant CGMP deviations in its manufacturing of APIs.[ Price : $8.95]
FDA releases a summary of changes to seven REMS shown on the REMS Web site in July and August.[ Price : $8.95]
Novartis says it will file a BLA and seek other global approvals for its leukemia drug Arzerra (ofatumumab) and its use in treatin...